Optimizing the clinical trial process to increase the chance of clinical and commercial success is a hot topic across the pharmaceutical industry, as witnessed by the number and range of attendees at Pharmaceutical Business Review’s recent webinar ‘Perspective on the future of drug development’…..read more
Tessella demonstated its Crystallographic Information System (CrysIS) at PSDI 2008, the annual Protein Structure Determination in Industry conference for structural biologists working in the pharmaceutical industry.
CrysIS manages the data and workflow of X-Ray protein crystallography from a request for a protein-compound, through the experiment and the final deposition of a protein-ligand structure, and the subsequent exploitation of [...]
Doris has been prepared for the Health Protection Agency by software company Tessella Support Services…read more
AIIM’s recent webinar on the Challenges and Benefits of Digital Preservation attracted a large and broad audience, confirming that digital preservation is now a mainstream issue. Attendees included business leaders from a range of industry sectors, including finance and pharmaceuticals, as well as traditional archiving specialists from national and state archives and libraries.
During the webinar, [...]
Tessella has been awarded a three-year call-off contract by Shell Global Solutions International to provide scientific and technical IT services in Europe, America and Asia.
Mark Claxton, Tessella’s Global Account Director for Shell commented: “For almost ten years, Tessella and Shell Global Solutions have worked together on the successful delivery of numerous and varied projects. Tessella [...]
Optimizing the clinical trial process to increase the chance of clinical and commercial success is a hot topic across the pharmaceutical industry, as witnessed by the number and range of attendees at Pharmaceutical Business Review’s recent webinar ‘Perspective on the future of drug development’.
Nick Bennett, Research & Analysis Director, Healthcare, at Datamonitor, said: “Pharma is [...]
